Memgen Competitors and Similar CompaniesClear all

Memgen's competitors and similar companies include TYME, Anavex and ROME Therapeutics.

	Memgen Memgen is a clinical-stage biotechnology company.	TYME TYME Technologies is a biotechnology company that develops cancer therapeutics.	Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.	ROME Therapeutics Rome Therapeutics is a company that develops therapies to cure cancer and autoimmune diseases.
Founding Date	Founding Date 2004	Founding Date 2011	Founding Date 2006	Founding Date 2020
Type	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech clinical research drug development healthtech life sciences oncology pharma therapy	Tags Healthcare oncology therapy
Locations	Locations Houston, US HQ	Locations New York, US HQ Bedminster, US	Locations New York, US HQ Reno, US	Locations Boston, US HQ
Employees	Employees 7	Employees 15	Employees 1623% increase	Employees 405% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 484.6 m	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income ($23.6m) (FY, 2022)	Net income ($46.4m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 865k (almost 7 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 50m (about 6 years ago)
Total funding raised	Total funding raised $ 8.5m	Total funding raised N/A	Total funding raised $ 12.6m	Total funding raised $ 50m